Detalhe da pesquisa
1.
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.
Nature
; 601(7893): 410-414, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794169
2.
SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice.
Eur J Immunol
; 53(12): e2250332, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37609807
3.
mRNA Cancer Vaccines.
Recent Results Cancer Res
; 209: 61-85, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28101688
4.
mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea.
Vaccines (Basel)
; 12(3)2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543894
5.
mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents.
NPJ Vaccines
; 8(1): 190, 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129390
6.
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models.
Vaccines (Basel)
; 11(2)2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851196
7.
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models.
Nat Commun
; 14(1): 816, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781853
8.
Progress in vaccine development for infectious diseases-a Keystone Symposia report.
Ann N Y Acad Sci
; 1524(1): 65-86, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020354
9.
Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent budding.
J Virol
; 85(7): 3546-56, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21191027
10.
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses.
Vaccines (Basel)
; 10(8)2022 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36016139
11.
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses.
Mol Ther Methods Clin Dev
; 27: 309-323, 2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36217434
12.
mRNA vaccines induce rapid antibody responses in mice.
NPJ Vaccines
; 7(1): 88, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35915094
13.
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents.
NPJ Vaccines
; 6(1): 57, 2021 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33863911
14.
mRNA Vaccines Induce Rapid Antibody Responses in Mice.
bioRxiv
; 2021 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34751269
15.
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.
Nat Commun
; 12(1): 4048, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193869
16.
Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity.
J Virol
; 82(6): 2918-29, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18094167
17.
New Vaccine Technologies to Combat Outbreak Situations.
Front Immunol
; 9: 1963, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30283434
18.
Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains.
Retrovirology
; 4: 70, 2007 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17908312
19.
Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
J Leukoc Biol
; 79(3): 616-27, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16365153
20.
RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines.
Methods Mol Biol
; 1499: 89-107, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27987144